
Conference Coverage
about 1 month ago
Why Patient Voices Matter: A Liver Cancer Advocate at ASCOabout 2 months ago
Top 5 Takeaways From EHA 2026 That Patients Should KnowLatest Content

Cat-Camel Exercise: A Gentle Way to Improve Spine Mobility During Cancer Recovery

Why Gene Silencing Could Change Polycythemia Vera Treatment

The First-Ever Personalized Cancer Vaccine to Pass a Phase 3 Trial Just Beat Keytruda Alone

"Lung Cancer Made Me Who I Am Today” : Juanita Segura on Her Journey and Finding Hope

The Cancer Search Bar: Understanding Lung Cancer, Staging and Treatment

Shorts










Podcasts
Videos
All News

In the phase 2 KEYPAD trial, Keytruda plus Xgeva shrank tumors in 31% of patients with advanced clear cell kidney cancer after prior treatment.

Leslie Waltke demonstrates gentle trunk rotations to help improve mobility in the lower and upper spine. Learn how to safely perform this exercise at home.

The phase 3 DESTINY-Lung04 trial met its main goal of keeping cancer from growing longer than chemotherapy plus immunotherapy did.

After reading another cancer survivor’s story, Sue McCarthy reflects on her own experience with guilt, her stage 3B lung cancer diagnosis and how helping others through a cancer support group helped her find confidence and purpose.

Cara Curcio’s melanoma journey changed her life as a wife and mother, but treatment, family and hope have kept her moving forward.

Nicole Schultz was treated for acute myeloid leukemia as a teenager. Two decades later, chronic graft-versus-host disease and ongoing survivorship monitoring remain part of her care.

A gynecologic oncologist on the testing that shapes treatment, the side effect not to push through and why fertility questions can't wait.

Sixteen years after treatment, cancer fatigue is still my constant shadow. I can't cure it, so I've learned to manage it instead of letting it manage me.

Dr. Priscilla Merriam discusses why sarcoma is often mistaken for a benign growth, how treatment differs across more than 150 types and where patients can find expert care.

The FDA granted accelerated approval to Zenbexus with daratumumab and hyaluronidase-fihj and dexamethasone for previously treated multiple myeloma.

Sixteen years after my own cancer journey, I find myself reflecting on the lasting shadows of cancer and the connection survivors can offer one another.

Genomic testing can show whether a targeted treatment may be an option. In a Medicare study, fewer than 1 in 5 patients with cancer received it in 2023.

Black women with ovarian cancer had a 45% higher risk of death than White women, with the gap widest in high-vulnerability neighborhoods.

Krystal Player-Jackson, oncology nurse of Ochsner LSU Shreveport, continued caring for cancer patients with compassion and resilience even while losing her father and brother to cancer weeks apart.

Nicole Schulz was 14 when she received an AML diagnosis. She shares what carried her through two transplants and 11 months in the hospital.





















